Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 525-535

  Rossiter, Harry B ^a   Scadeng, Miriam ^b   Tang, Kechun ^c   Wagner, Peter D ^c   Breen, Ellen C ^c,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cre recombinase; Extracellular matrix; Magnetic resonance imaging; Serpin b5; Tissue inhibitor of metalloproteinase

Indexed keywords

CRE RECOMBINASE; D 9891; DOXYCYCLINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; GENE INACTIVATION; LUNG INFLATION; LUNG INJURY; LUNG PARENCHYMA; LUNG STRUCTURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANIMALS; DOXYCYCLINE; GENE EXPRESSION REGULATION; LUNG; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; PULMONARY ALVEOLI; RATS; SERPINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 43449101547     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21643     Document Type: Article

References (47)

1. Ahuja TS. 2003. Doxycycline decreases proteinuria in glomerulonephritis. Am J Kidney Dis 42:376-380.
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744.
3. Churg A, Wang RD, Xie C, Wright JL. 2003. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 168: 199-207.
4. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71:955-961.
5. Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH, Haley KJ, Sylvia JS, Sparrow D, Spira AE, Beane J, Pinto-Plata V, Speizer FE, Shapiro SD, Weiss ST, Silverman EK. 2006. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 78:253-264.
6. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. 1999. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: Light, fluorescence, and electron microscopy. Anat Rec 254:61-73.
7. Franco C, Ho B, Mulholland D, Hou G, Islam M, Donaldson K, Bendeck MP. 2006. Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. Am J Pathol 168:1697-1709.
8. Fujita M, Ye Q, Ouchi H, Harada E, Inoshima I, Kuwano K, Nakanishi Y. 2006. Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice. Antimicrob Agents Chemother 50:739-743.
9. Fujita M, Harada E, Ikegame S, Ye Q, Ouchi H, Inoshima I, Nakanishi Y. 2007. Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function. Pulm Pharmacol Ther 20:669-675.
10. Garcia RA, Go KV, Villarreal FJ. 2007. Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem 300:159-169.
11. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. 1999. VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159.
12. Gill SE, Pape MC, Leco KJ. 2006. Tissue inhibitor of metalloproteinases 3 regulates extracellular matrix-cell signaling during bronchiole branching morphogenesis. Dev Biol 298:540-554.
13. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. 1998. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26.
14. Griffin MO, Jinno M, Miles LA, Villarreal FJ. 2005. Reduction of myocardial infarct size by doxycycline: A role for plasmin inhibition. Mol Cell Biochem 270:1-11.
15. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103-106.
16. Gueders MM, Foidart JM, Noel A, Cataldo DD. 2006. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases. Eur J Pharmacol 533:133-144.
17. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004.
18. Hosford GE, Fang X, Olson DM. 2004. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: Association with arrested alveolarization. Pediatr Res 56:26-34.
19. Imamura T, Matsushita K, Travis J, Potempa J. 2001. Inhibition of trypsin-like cysteine proteinases (gingi-pains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 45: 2871-2876.
20. Jantzie LL, Cheung PY, Todd KG. 2005. Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 25:314-324.
21. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163:737-744.
22. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. 2002. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166:382-385.
23. Latha K, Zhang W, Cella N, Shi HY, Zhang M. 2005. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol 25:1737-1748.
24. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW, Khokha R. 2001. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108:817-829.
25. Lee KS, Jin SM, Kim SS, Lee YC. 2004. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 113:902-909.
26. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. 2005. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169:681-691.
27. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. 2003. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes MMP12-dependent emphysema. Nature 422:169-173.
28. Moses MA, Harper J, Folkman J. 2006. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med 354:2621-2622.
29. Naini AE, Harandi AA, Moghtaderi J, Bastani B, Amiran A. 2007. Doxycycline: A pilot study to reduce diabetic proteinuria. Am J Nephrol 27:269-273.
30. Peterson JT. 2004. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev 9:63-79.
31. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, Zhang B, Song S, Hicklin D, Voelkel NF, Flotte T, Tuder RM. 2006. A novel anti-apoptotic role for alpha-1 antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 173:1222-1228.
32. Scadeng M, Rossiter HB, Dubowitz DJ, Breen EC. 2007. High-resolution three-dimensional magnetic resonance imaging of mouse lung in situ. Invest Radiol 42: 50-57.
33. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A. 2000. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279:L562-L574.
34. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. 2003. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163:2329-2335.
35. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J. 2006. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169:1390-1401.
36. Sorsa T, Lindy O, Konttinen YT, Suomalainen K, Ingman T, Saari H, Halinen S, Lee HM, Golub LM, Hall J, Simon S. 1993. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 37:592-594.
37. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
38. Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G. 2006. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration 73:185-190.
39. Tang K, Rossiter HB, Wagner PD, Breen EC. 2004. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 97:1559-1566.
40. Thurlbeck WM. 1967. Internal surface area and other measurements in emphysema. Thorax 22:483-496.
41. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA, Jr., Shapiro SD, Elias JA. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192:1587-1600.
42. Wright JL, Churg A. 2007. Current concepts in mechanisms of emphysema. Toxicol Pathol 35:111-115.
43. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-2232.
44. Zhang M, Volpert O, Shi YH, Bouck N. 2000. Maspin is an angiogenesis inhibitor. Nat Med 6:196-199.
45. Zhang X, Shan P, Jiang G, Cohn L, Lee PJ. 2006. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116:3050-3059.
46. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ, Jr., Chapman HA, Jr., Shapiro SD, Elias JA. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106:1081-1093.
47. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. 1994. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529.